Koyfin Home > Directory > Health Care > Nymox Pharm Corp > Long-term Debt / Equity

Nymox Pharm Corp Long-term Debt / Equity Chart (NYMX)

Nymox Pharm Corp annual/quarterly Long-term Debt / Equity from 2014 to 2020.
  • Nymox Pharm Corp Long-term Debt / Equity for the quarter ending June 06, 2020 was $-10m a 127.32% decrease of -12m year over year
  • Nymox Pharm Corp Long-term Debt / Equity for the last 12 months ending June 06, 2020 was $-10m a 127.32% decrease of -12m year over year
  • Nymox Pharm Corp Annual Long-term Debt / Equity for 2019 was $0m a 21,952.76% increase of 19m from 2018
  • Nymox Pharm Corp Annual Long-term Debt / Equity for 2014 was $-19m
Other Ratios Metrics:
  • Nymox Pharm Corp Total Debt / Capital for the quarter ending September 09, 2017 was $98m a 78.16% increase of 77m year over year
  • Nymox Pharm Corp Other Liabilities for the quarter ending December 12, 2016 was $0m a 208,053.10% decrease of -2m year over year
  • Nymox Pharm Corp Total Debt / Equity for the quarter ending September 09, 2017 was $6,192m a 99.37% increase of 6,153m year over year
View Chart On Koyfin

Quarterly NYMX Long-term Debt / Equity Data

06/2020$-10m
03/2020$9m
12/2019$0m
09/2019$3m
06/2019$3m
03/2019$3m
03/2017$-82m
09/2016$-88m
06/2016$-48m
03/2016$-76m

Annual NYMX Long-term Debt / Equity Data

2019$0m
2014$-19m